1. |
Nakajima T, Deguchi T, Kagawa K, et al. Identification ofapoptotic hepatocytes in situ in rat liver after lead nitrate administration[J]. J Gastroenterol, 1995, 30(6): 725-730.
|
2. |
Kubo K, Matsuzaki Y, Okazaki M. The Fas system is notsignificantly involved in apoptosis in human hepatocellular carcinoma[J]. Liver, 1998, 18(2): 117-123.
|
3. |
Heyninck K, De Valck D, Vanden Berghe W, et al. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN[J] . J Cell Biol, 1999, 145(7): 1471-1482..
|
4. |
Arsura M, Cavin LG. Nuclear factor-kappaB and liver carcinogenesis[J]. Cancer Lett, 2005, 229(2): 157-169.
|
5. |
Hinz M, Krappmann D, Eichten A, et al. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition[J]. Mol Cell Biol, 1999, 19(4): 2690-2698.
|
6. |
刘晓. 核转录因子NF-κB与肿瘤[J]. 实用肿瘤学杂志, 2007, 21(2): 191-193.
|
7. |
Sharom FJ. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1)[J]. Biochem Cell Biol, 2006, 84(6): 979-992.
|
8. |
Zhang F, Ren G, Lu Y, et al. Identification of TRAK1 (trafficking protein, kinesin-binding 1) as MGb2-Ag: a novel cancer biomarker[J]. Cancer Lett, 2009, 274(2): 250-258.
|
9. |
Dixit VM, Green S, Sarma V, et al. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin[J]. J Biol Chem, 1990, 265(5): 2973-2978.
|
10. |
徐明清, 严律南, 苟兴华, 等. 锌指蛋白A20促进同种异体大鼠小体积移植肝脏再生并抑制急性排斥[J]. 中国普外基础与临床杂志, 2008, 15(8): 572-578.
|
11. |
Amiri KI, Richmond A. Role of nuclear factor kappa B in melanoma[J]. Cancer Metastasis Rav, 2005, 24(2): 301-313.
|
12. |
Pikarsky E, Porat RM, Stein I, et al. NF-kappaB function as a tumor promoter in inflammation-associated cancer[J]. Nature, 2004, 431(7007): 461-466.
|
13. |
Sclabas GM, Uwagawa T, Schmidt C, et al. Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin[J]. Cancer, 2005, 103(12): 2485-2490.
|
14. |
Kojima M, Morisaki T, Sasaki N, et al. Increased nuclear factor-κBactivation in human colorectal carcinoma and its correlation with tumor progression[J]. Anticancer Res, 2004, 24(2B): 675-681.
|
15. |
Hanahan D, Weinberg RA. The hallmarks of cancer[J]. Cell, 2000, 100(1): 57-70.
|
16. |
Aggarwal BB. Nuclear factor kappa B: the enemy within[J]. Cancer Cell, 2004,6(3): 203-208.
|
17. |
秦安, 蔡兵, 王彤, 等. 肝细胞肝癌中survivin、caspase-3和NF-κB的表达及其相关性[J]. 南京医科大学学报:自然科学版, 2009, 29(7): 953-957..
|
18. |
Ruefli AA, Smyth MJ, Johnstone RW. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance[J]. Blood, 2000, 95(7): 2378-2385.
|
19. |
Campone M, Vavasseur F, Le Cabellec MT, et al. Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein[J]. Leukemia, 2001, 15(9): 1377-1387.
|
20. |
Lacueva FJ, Calpena R, Medrano J, et al. Changes in P-glycoprotein expression in gastric carcinoma with respect to distantgastric mucosa may be influenced by p53[J]. Cancer, 2000, 89(1): 21-28.
|